| Print
Adial Pharmaceuticals (ADIL)
Common SharesNot yet a customer?
Low cost dealing from £1.50Choose from our range of SIPP, ISA and Dealing accounts
Find out moreThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Address
Forecast key dates
| Name | Key Date |
|---|---|
| Adial Pharmaceuticals Inc Second Quarter Earnings Results for 2026 | 2026-08-14T00:00:00 |
| Adial Pharmaceuticals Inc First Quarter Earnings Results for 2026 | 2026-05-15T00:00:00 |
| Adial Pharmaceuticals Inc Fourth Quarter Earnings Results for 2025 | 2026-03-04T00:00:00 |
| Adial Pharmaceuticals Inc Annual Report for 2025 | 2026-03-04T00:00:00 |
| Adial Pharmaceuticals Inc Third Quarter Earnings Results for 2025 | 2025-11-13T00:00:00 |
| Adial Pharmaceuticals Inc Annual General Meeting for 2025 | 2025-11-12T08:30:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Adial Pharmaceuticals Inc Second Quarter Earnings Results for 2025 | 2025-08-14T00:00:00 |
| Adial Pharmaceuticals Inc First Quarter Earnings Results for 2025 | 2025-05-15T00:00:00 |
| Adial Pharmaceuticals Inc Fourth Quarter Earnings Results for 2024 | 2025-03-04T00:00:00 |
| Adial Pharmaceuticals Inc Annual Report for 2024 | 2025-03-04T00:00:00 |
| Adial Pharmaceuticals Inc Third Quarter Earnings Results for 2024 | 2024-11-13T00:00:00 |
| Adial Pharmaceuticals Inc Annual General Meeting for 2024 | 2024-11-12T08:30:00 |
| 2024 ThinkEquity Conference | 2024-10-30T08:30:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.